An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults

Authors: di Valserra M.d.B.; Zanasi A.; Ragusa S.; Gluck R.; Herzog C.

Source: Clinical Therapeutics, Volume 24, Number 1, January 2002 , pp. 100-111(12)

Publisher: Elsevier

Keywords: influenza; vaccine; intranasal; virosomal; Escherichia coli heat-labile toxin

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0149-2918(02)85008-1

Affiliations: 1: Berna Biotech Ltd, , Berne, Switzerland

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: di Valserra M.d.B. ;  Zanasi A. ;  Ragusa S. ;  Gluck R. ;  Herzog C.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers